-The Times of India HYDERABAD: Is Bt Brinjal safe? The demonisation of BT crops got a push with the parliamentary committee on agriculture in its report submitted last month commenting that transgenics in food crops would be fraught with unknown consequences. But the Hyderabad-based National Institute of Nutrition (NIN) of the Indian Council of Medical Research (ICMR) says that Bt Brinjal is safe. A voluminous report on the laboratory experiments carried out...
More »SEARCH RESULT
Stepping up pace on the long road to TB control -Virander S Chauhan
-The Hindu Tuberculosis (TB) has remained a major infectious disease in developing and poor countries despite all efforts from health agencies to manage and control it. In fact, even an easy and effective way to diagnose the disease has remained a challenge. Emergence of drug resistant strains has made its management more complex. The steps It makes the situation in countries like India, with the highest TB burden in the world, even more...
More »Patients lose out to patents & profits -Deepa Kurup
-The Hindu A 2012 WHO study ranks India third — behind Myanmar and Bangladesh — among countries that fail to provide health cover to people. A 2011 study reported in The Lancet on ‘Healthcare and equity’ confirms this: every year, at least 39 million people here fall into poverty due to private out-of-pocket health expenditure. A vast majority of Indians do not have access to healthcare or essential drugs. By the...
More »New mobile radiation norms from today
-PTI New radiation norms for telecom towers come into force from tomorrow, allowing only a tenth of the emission permitted by the existing guidelines. The move is a precautionary one aimed at addressing public health concerns, although a government-appointed expert panel has found no direct link between health and exposure to the electromagnetic frequency radiation from mobile towers. The bulk of the expected fall in emission levels has already been achieved, since 95...
More »CDSCO drafting new norms for financial compensation-Mahim Pratap Singh
-The Hindu In the year 2011, 438 people died due to Serious Adverse Events (SAEs) during medicine trials in India, but pharmaceutical companies provided financial compensation in only 16 such cases. The total amount paid in compensation in all the 16 cases adds up to Rs. 34.88 lakh, with the highest amount being Rs. 5 lakh, and the lowest being Rs. 50,000. This makes 2011 only the second year, for which data are...
More »